Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Development and assessment of a novel ex vivo corneal culture technique involving an agarose-based dome scaffold for use as a model of in vivo corneal wound healing in dogs and rabbits.

Berkowski WM Jr, Gibson DJ, Craft SL, Whitley RD, Schultz GS, Plummer CE.

Am J Vet Res. 2020 Jan;81(1):47-57. doi: 10.2460/ajvr.81.1.47.

PMID:
31887084
2.

Modulating Ocular Scarring in Glaucoma Filtration Surgery Using the Epigenetic Adjunct Suberoylanilide Hydroxamic Acid.

Rodgers CD, Lukowski ZL, Min J, Martorana GM, Wilson MK, Schaefer JL, Levine MA, Meyers CA, Blake CR, Schultz GS, Sherwood MB.

J Curr Glaucoma Pract. 2019 Jan-Apr;13(1):37-41. doi: 10.5005/jp-journals-10078-1246.

3.

Interleukin-6 and body mass index, tobacco use, and sleep in gynecologic cancers.

Kacel EL, Kirsch JL, Sannes TS, Patidar S, Postupack R, Jensen S, Wong S, Garey S, Dodd S, Ulfig CM, McCrae CS, Robinson ME, Castagno J, Schultz GS, Pereira DB.

Health Psychol. 2019 Oct;38(10):866-877. doi: 10.1037/hea0000775. Epub 2019 Aug 1.

PMID:
31368718
4.

Cadexomer iodine effectively reduces bacterial biofilm in porcine wounds ex vivo and in vivo.

Roche ED, Woodmansey EJ, Yang Q, Gibson DJ, Zhang H, Schultz GS.

Int Wound J. 2019 Jun;16(3):674-683. doi: 10.1111/iwj.13080. Epub 2019 Mar 13.

5.

TIME CDST: an updated tool to address the current challenges in wound care.

Moore Z, Dowsett C, Smith G, Atkin L, Bain M, Lahmann NA, Schultz GS, Swanson T, Vowden P, Weir D, Zmuda A, Jaimes H.

J Wound Care. 2019 Mar 3;28(3):154-161. doi: 10.12968/jowc.2019.28.3.154.

6.

Implementing TIMERS: the race against hard-to-heal wounds.

Atkin L, Bućko Z, Conde Montero E, Cutting K, Moffatt C, Probst A, Romanelli M, Schultz GS, Tettelbach W.

J Wound Care. 2019 Mar 1;23(Sup3a):S1-S50. doi: 10.12968/jowc.2019.28.Sup3a.S1. No abstract available.

7.

Assessment of Topical Therapies for Improving the Optical Clarity Following Stromal Wounding in a Novel Ex Vivo Canine Cornea Model.

Berkowski WM, Gibson DJ, Seo S, Proietto LR, Whitley RD, Schultz GS, Plummer CE.

Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5509-5521. doi: 10.1167/iovs.17-23085.

PMID:
30658034
8.

Principles of Wound Healing.

Schultz GS, Chin GA, Moldawer L, Diegelmann RF.

In: Fitridge R, Thompson M, editors. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists [Internet]. Adelaide (AU): University of Adelaide Press; 2011. No abstract available. 23.

9.

A Surfactant-Based Dressing to Treat and Prevent Acinetobacter baumannii Biofilms.

Yang Q, Schultz GS, Gibson DJ.

J Burn Care Res. 2018 Aug 17;39(5):766-770. doi: 10.1093/jbcr/irx041.

PMID:
29931339
10.

In Vivo Knockdown of the Herpes Simplex Virus 1 Latency-Associated Transcript Reduces Reactivation from Latency.

Watson ZL, Washington SD, Phelan DM, Lewin AS, Tuli SS, Schultz GS, Neumann DM, Bloom DC.

J Virol. 2018 Jul 31;92(16). pii: e00812-18. doi: 10.1128/JVI.00812-18. Print 2018 Aug 15.

11.

Effectiveness of a monofilament wound debridement pad at removing biofilm and slough: ex vivo and clinical performance.

Schultz GS, Woo K, Weir D, Yang Q.

J Wound Care. 2018 Feb 2;27(2):80-90. doi: 10.12968/jowc.2018.27.2.80.

PMID:
29424644
12.

Proactive and Early Aggressive Wound Management: A Shift in Strategy Developed by a Consensus Panel Examining the Current Science, Prevention, and Management of Acute and Chronic Wounds.

Bohn GA, Schultz GS, Liden BA, Desvigne MN, Lullove EJ, Zilberman I, Regan MB, Ostler M, Edwards K, Arvanitis GM, Hartman JF.

Wounds. 2017 Nov;29(11):S37-S42.

PMID:
29166254
13.

Dual-Phase Iontophoresis for the Delivery of Antisense Oligonucleotides.

Gibson DJ, Tuli SS, Schultz GS.

Nucleic Acid Ther. 2017 Aug;27(4):238-250. doi: 10.1089/nat.2016.0654. Epub 2017 Apr 4.

14.

Connective tissue growth factor is not necessary for haze formation in excimer laser wounded mouse corneas.

Feng X, Pi L, Sriram S, Schultz GS, Gibson DJ.

PLoS One. 2017 Feb 16;12(2):e0172304. doi: 10.1371/journal.pone.0172304. eCollection 2017.

15.

Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria.

Abouelhassan Y, Yang Q, Yousaf H, Nguyen MT, Rolfe M, Schultz GS, Huigens RW 3rd.

Int J Antimicrob Agents. 2017 Feb;49(2):247-251. doi: 10.1016/j.ijantimicag.2016.10.017. Epub 2016 Dec 6.

PMID:
28110918
16.

Testing the influence of surfactant-based wound dressings on proteinase activity.

Jeong S, Schultz GS, Gibson DJ.

Int Wound J. 2017 Oct;14(5):786-790. doi: 10.1111/iwj.12697. Epub 2016 Dec 8.

PMID:
27933737
17.

Adeno-associated Virus Vectors Efficiently Transduce Mouse and Rabbit Sensory Neurons Coinfected with Herpes Simplex Virus 1 following Peripheral Inoculation.

Watson ZL, Ertel MK, Lewin AS, Tuli SS, Schultz GS, Neumann DM, Bloom DC.

J Virol. 2016 Aug 12;90(17):7894-901. doi: 10.1128/JVI.01028-16. Print 2016 Sep 1.

18.

A surfactant-based wound dressing can reduce bacterial biofilms in a porcine skin explant model.

Yang Q, Larose C, Della Porta AC, Schultz GS, Gibson DJ.

Int Wound J. 2017 Apr;14(2):408-413. doi: 10.1111/iwj.12619. Epub 2016 May 22.

PMID:
27212453
19.

Evaluation of a bilayered, micropatterned hydrogel dressing for full-thickness wound healing.

Magin CM, Neale DB, Drinker MC, Willenberg BJ, Reddy ST, La Perle KM, Schultz GS, Brennan AB.

Exp Biol Med (Maywood). 2016 May;241(9):986-95. doi: 10.1177/1535370216640943. Epub 2016 Mar 31.

20.

Connective tissue growth factor differentially binds to members of the cystine knot superfamily and potentiates platelet-derived growth factor-B signaling in rabbit corneal fibroblast cells.

Pi L, Chung PY, Sriram S, Rahman MM, Song WY, Scott EW, Petersen BE, Schultz GS.

World J Biol Chem. 2015 Nov 26;6(4):379-88. doi: 10.4331/wjbc.v6.i4.379.

21.

Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.

Martorana GM, Schaefer JL, Levine MA, Lukowski ZL, Min J, Meyers CA, Schultz GS, Sherwood MB.

PLoS One. 2015 Sep 22;10(9):e0138054. doi: 10.1371/journal.pone.0138054. eCollection 2015.

22.

Medical Honey and Silver Dressings Do Not Interfere with Each Other's Key Functional Attributes.

Gibson DJ, Yang Q, Kerekes DT, Schultz GS.

Wounds. 2014 Nov;26(11):309-16.

PMID:
25856165
23.

A disintegrin and metalloprotease with thrombospondin type I motif 7: a new protease for connective tissue growth factor in hepatic progenitor/oval cell niche.

Pi L, Jorgensen M, Oh SH, Protopapadakis Y, Gjymishka A, Brown A, Robinson P, Liu C, Scott EW, Schultz GS, Petersen BE.

Am J Pathol. 2015 Jun;185(6):1552-63. doi: 10.1016/j.ajpath.2015.02.008. Epub 2015 Apr 2.

24.

Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice.

Pi L, Robinson PM, Jorgensen M, Oh SH, Brown AR, Weinreb PH, Trinh TL, Yianni P, Liu C, Leask A, Violette SM, Scott EW, Schultz GS, Petersen BE.

Hepatology. 2015 Feb;61(2):678-91. doi: 10.1002/hep.27425.

25.

Chronic wounds with emphasis in diabetic foot ulcers.

Berlanga-Acosta J, Armstrong DG, Schultz GS, Herrera-Martinez L.

Biomed Res Int. 2014;2014:890352. doi: 10.1155/2014/890352. Epub 2014 Mar 17. No abstract available.

26.

Conditional knockout of CTGF affects corneal wound healing.

Gibson DJ, Pi L, Sriram S, Mao C, Petersen BE, Scott EW, Leask A, Schultz GS.

Invest Ophthalmol Vis Sci. 2014 Apr 1;55(4):2062-70. doi: 10.1167/iovs.13-12735.

27.

Molecular Wound Assessments: Matrix Metalloproteinases.

Gibson DJ, Schultz GS.

Adv Wound Care (New Rochelle). 2013 Feb;2(1):18-23. Review.

28.
29.

Topical application of recombinant platelet-derived growth factor increases the rate of healing and the level of proteins that regulate this response.

Gowda S, Weinstein DA, Blalock TD, Gandhi K, Mast BA, Chin G, Schultz GS.

Int Wound J. 2015 Oct;12(5):564-71. doi: 10.1111/iwj.12165. Epub 2013 Oct 7.

PMID:
24118782
30.

MicroRNA signature in wound healing following excimer laser ablation: role of miR-133b on TGFβ1, CTGF, SMA, and COL1A1 expression levels in rabbit corneal fibroblasts.

Robinson PM, Chuang TD, Sriram S, Pi L, Luo XP, Petersen BE, Schultz GS.

Invest Ophthalmol Vis Sci. 2013 Oct 23;54(10):6944-51. doi: 10.1167/iovs.13-12621.

31.

A corneal scarring model.

Gibson DJ, Schultz GS.

Methods Mol Biol. 2013;1037:277-98. doi: 10.1007/978-1-62703-505-7_16.

PMID:
24029942
32.

Antimicrobial dressing efficacy against mature Pseudomonas aeruginosa biofilm on porcine skin explants.

Phillips PL, Yang Q, Davis S, Sampson EM, Azeke JI, Hamad A, Schultz GS.

Int Wound J. 2015 Aug;12(4):469-83. doi: 10.1111/iwj.12142. Epub 2013 Sep 13.

PMID:
24028432
33.

Development of a novel ex vivo porcine skin explant model for the assessment of mature bacterial biofilms.

Yang Q, Phillips PL, Sampson EM, Progulske-Fox A, Jin S, Antonelli P, Schultz GS.

Wound Repair Regen. 2013 Sep-Oct;21(5):704-14. doi: 10.1111/wrr.12074. Epub 2013 Aug 8.

PMID:
23927831
34.

The progression of haze formation in rabbit corneas following phototherapeutic keratectomy.

Gibson DJ, Tuli SS, Schultz GS.

Invest Ophthalmol Vis Sci. 2013 Jul 16;54(7):4776-81. doi: 10.1167/iovs.13-11976.

35.

Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing.

Berlanga-Acosta J, Schultz GS, López-Mola E, Guillen-Nieto G, García-Siverio M, Herrera-Martínez L.

Biomed Res Int. 2013;2013:256043. doi: 10.1155/2013/256043. Epub 2012 Dec 26. Review.

36.

Proteolytic processing of connective tissue growth factor in normal ocular tissues and during corneal wound healing.

Robinson PM, Smith TS, Patel D, Dave M, Lewin AS, Pi L, Scott EW, Tuli SS, Schultz GS.

Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8093-103. doi: 10.1167/iovs.12-10419.

37.

Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts.

Radhakrishnan SS, Blalock TD, Robinson PM, Secker G, Daniels J, Grotendorst GR, Schultz GS.

Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8076-85. doi: 10.1167/iovs.12-10790.

38.

Ectopic epithelial implants following surface ablation of the cornea.

Gibson DJ, Schultz GS.

Invest Ophthalmol Vis Sci. 2012 Nov 21;53(12):7760-5. doi: 10.1167/iovs.12-10768.

39.

Comparison of single versus multiple injections of the protein saratin for prolonging bleb survival in a rabbit model.

Min J, Lukowski ZL, Levine MA, Meyers CA, Beattie AR, Schultz GS, Samuelson DA, Sherwood MB.

Invest Ophthalmol Vis Sci. 2012 Nov 19;53(12):7625-30. doi: 10.1167/iovs.12-10120.

PMID:
23033390
40.

Microbial barriers.

Gutwein LG, Panigrahi M, Schultz GS, Mast BA.

Clin Plast Surg. 2012 Jul;39(3):229-38. doi: 10.1016/j.cps.2012.04.002. Epub 2012 May 22. Review.

PMID:
22732372
41.

Molecular Mechanisms of Biofilm Infection: Biofilm Virulence Factors.

Phillips PL, Schultz GS.

Adv Wound Care (New Rochelle). 2012 Jun;1(3):109-114. Review.

42.

CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators.

Pi L, Shenoy AK, Liu J, Kim S, Nelson N, Xia H, Hauswirth WW, Petersen BE, Schultz GS, Scott EW.

FASEB J. 2012 Aug;26(8):3365-79. doi: 10.1096/fj.11-200154. Epub 2012 May 18.

43.

Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model.

Min J, Lukowski ZL, Levine MA, Meyers CA, Beattie AR, Schultz GS, Samuelson DA, Sherwood MB.

PLoS One. 2012;7(4):e35627. doi: 10.1371/journal.pone.0035627. Epub 2012 Apr 30.

44.

A connective tissue growth factor signaling receptor in corneal fibroblasts.

Blalock TD, Gibson DJ, Duncan MR, Tuli SS, Grotendorst GR, Schultz GS.

Invest Ophthalmol Vis Sci. 2012 Jun 5;53(7):3387-94. doi: 10.1167/iovs.12-9425.

45.

Vorinostat: a potent agent to prevent and treat laser-induced corneal haze.

Tandon A, Tovey JC, Waggoner MR, Sharma A, Cowden JW, Gibson DJ, Liu Y, Schultz GS, Mohan RR.

J Refract Surg. 2012 Apr;28(4):285-90. doi: 10.3928/1081597X-20120210-01. Epub 2012 Mar 1.

46.

Hammerhead ribozyme-mediated knockdown of mRNA for fibrotic growth factors: transforming growth factor-beta 1 and connective tissue growth factor.

Robinson PM, Blalock TD, Yuan R, Lewin AS, Schultz GS.

Methods Mol Biol. 2012;820:117-32. doi: 10.1007/978-1-61779-439-1_8.

47.

Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.

Mohan RR, Tovey JC, Sharma A, Schultz GS, Cowden JW, Tandon A.

PLoS One. 2011;6(10):e26432. doi: 10.1371/journal.pone.0026432. Epub 2011 Oct 19.

48.

Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.

Lukowski ZL, Min J, Beattie AR, Meyers CA, Levine MA, Stoller G, Schultz GS, Samuelson DA, Sherwood MB.

J Glaucoma. 2013 Feb;22(2):145-51. doi: 10.1097/IJG.0b013e31822e8c83.

49.

Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury.

Benson JM, Seagrave J, Weber WM, Santistevan CD, Grotendorst GR, Schultz GS, March TH.

Wound Repair Regen. 2011 May-Jun;19(3):348-57. doi: 10.1111/j.1524-475X.2011.00675.x. Epub 2011 Mar 16.

50.

Dynamic reciprocity in the wound microenvironment.

Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM.

Wound Repair Regen. 2011 Mar-Apr;19(2):134-48. doi: 10.1111/j.1524-475X.2011.00673.x. Review.

Supplemental Content

Loading ...
Support Center